MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
Clinical trial NCT07045571 · RECRUITING
Trial details
- NCT number
- NCT07045571
- Sponsor
- Yingbin Liu, MD, PhD, FACS
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-30
- Primary completion
- 2026-01-22
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.